The immune response to DNA damage
Breast cancer is a highly heterogenous disease and current methods of treatment selection in the clinic do not take account of this heterogeneity. In order to improve outcomes in breast cancer, a personalised approach is required. Previously we identifed a DNA damage response deficient (DDRD) molecu...
| Main Author: | |
|---|---|
| Published: |
Queen's University Belfast
2016
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.709693 |